Self-preserving gelatin emulgel containing whole cell probiotic for topical use: preclinical safety, efficacy, and germination studies. (2nd November 2021)
- Record Type:
- Journal Article
- Title:
- Self-preserving gelatin emulgel containing whole cell probiotic for topical use: preclinical safety, efficacy, and germination studies. (2nd November 2021)
- Main Title:
- Self-preserving gelatin emulgel containing whole cell probiotic for topical use: preclinical safety, efficacy, and germination studies
- Authors:
- Sharma, Garima
Sharma, Manuhaar
Sood, Rishav
Neelamraju, Jayanthi
Lakshmi, Suvarna G.
Madempudi, Ratna Sudha
Rishi, Praveen
Kaur, Indu Pal - Abstract:
- ABSTRACT: Background: Dermal disorders, owing to disruption of skin-microflora balance can be served by direct application of probiotics. However, there are few topical whole probiotic products in market because of (i) loss of viability during manufacturing and storage(ii) inadequate germination and retention on skin. Presently we report a novel (IPA 201811010395) emulgel incorporating Bacillus coagulans (Unique IS-2) for possible topical use. Methods: Developed emulgel was characterized for particle size, texture, rheology, morphology, water activity, self-preservation, safety, and stability. Results: We successfully incorporated 97 ± 5% (1.7×10 8 CFU/g) Bacillus coagulans in honeycomb network of gelatin nanoparticles (≈ 600 nm). Maintenance of CFU at 30 ± 2°C, 65 ± 5% RH for 3 months confirmed viability of incorporated probiotic. Low water-activity (0.66–0.732aw ) and challenge test (0.05–0.5% viability) confirmed its self-preserving nature. Early initiation (6 h) and complete (24 h) spore germination was evident onrabbit skin. No cytotoxicity, dermal irritation or translocation established its safety. Faster wound closure and reduced oxidative stress (LPO, catalase, SOD, glutathione reductase) in comparison to Soframycin® (1%w/w Framycetin) was observed in excision wound in mice. Conclusions: A whole cell probiotic formulation that is self-preserving, maintains probiotic viability, guarantees germination, and has wound healing properties was successfully formulated.
- Is Part Of:
- Expert opinion on drug delivery. Volume 18:Number 11(2021)
- Journal:
- Expert opinion on drug delivery
- Issue:
- Volume 18:Number 11(2021)
- Issue Display:
- Volume 18, Issue 11 (2021)
- Year:
- 2021
- Volume:
- 18
- Issue:
- 11
- Issue Sort Value:
- 2021-0018-0011-0000
- Page Start:
- 1777
- Page End:
- 1789
- Publication Date:
- 2021-11-02
- Subjects:
- Bacillus coagulans Unique IS-2 -- emulgel -- gelatin -- germination -- probiotics -- wound
Drug delivery devices -- Periodicals
Drug delivery systems -- Periodicals
615.605 - Journal URLs:
- http://informahealthcare.com/journal/edd ↗
http://www.ashley-pub.com/?cookieSet=1 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/17425247.2021.1947239 ↗
- Languages:
- English
- ISSNs:
- 1742-5247
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002941
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19959.xml